Susanna Naggie

Susanna Naggie

UNVERIFIED PROFILE

Are you Susanna Naggie?   Register this Author

Register author
Susanna Naggie

Susanna Naggie

Publications by authors named "Susanna Naggie"

Are you Susanna Naggie?   Register this Author

85Publications

1636Reads

49Profile Views

Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?

Dig Dis Sci 2019 Dec 23;64(12):3394-3401. Epub 2019 Oct 23.

Section of Gastroenterology and Hepatology, Ralph H. Johnson VAMC, Charleston, SC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05861-7DOI Listing
December 2019

Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.

Cell Mol Gastroenterol Hepatol 2019 Dec 25. Epub 2019 Dec 25.

Division of Gastroenterology, Duke University, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcmgh.2019.12.006DOI Listing
December 2019

Hepatitis C Behind and Beyond Bars: Targeting the US Prison Population and Changing North Carolina Prisoner Health Policy.

N C Med J 2019 Nov-Dec;80(6):352-355

associate professor of medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18043/ncm.80.6.352DOI Listing
November 2019

Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus.

Am J Cardiol 2019 09 29;124(6):966-971. Epub 2019 Jun 29.

Division of Cardiology, Department of Medicine, Yale University, Yale New Haven Health System, New Haven, Connecticut. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2019.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887515PMC
September 2019

Management of Hepatitis C in 2019.

JAMA 2019 May 17. Epub 2019 May 17.

Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2019.5353DOI Listing
May 2019

Sustained Virologic Response in People Who Inject Drugs and/or Who Are on Opioid Agonist Therapy: Is 90% Enough?

Hepatol Commun 2019 Apr 1;3(4):453-455. Epub 2019 Apr 1.

Family Health Centers of San Diego San Diego CA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep4.1347
Publisher Site
http://dx.doi.org/10.1002/hep4.1347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442701PMC
April 2019

Treating HCV Infection: It Doesn't Get Much Better Than This.

Authors:
Susanna Naggie

Top Antivir Med 2019 Jan;26(4):104-108

Duke University School of Medicine, Druham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372361PMC
January 2019

The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.

Contemp Clin Trials 2018 09 10;72:73-85. Epub 2018 Jul 10.

Division of Gastroenterology, Department of Medicine, Duke University School of Medicine, DUMC 3913, Durham, NC 27710, USA; Duke Clinical Research Institute, 2400 Pratt Street, Rm. 0311, Terrace Level, Durham, NC 27705, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2018.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711183PMC
September 2018

Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort.

J Card Fail 2018 Aug 30;24(8):496-503. Epub 2018 Jun 30.

Division of Cardiology, Department of Medicine; Duke Clinical Research Institute, Duke University Medical Center,; Duke Global Health Institute, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2018.06.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231907PMC
August 2018

Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.

Infect Dis Clin North Am 2018 06;32(2):407-423

Division of Infectious Diseases, Duke University Medical Center, 315 Trent Drive, Hanes House, Room 181, DUMC Box 102359, Durham, NC 27710, USA; Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27705, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.idc.2018.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592269PMC
June 2018

Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.

Open Forum Infect Dis 2018 Jan 9;5(1):ofx264. Epub 2017 Dec 9.

Division of Infectious Diseases, Duke University, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofx264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753271PMC
January 2018

The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets.

Open Forum Infect Dis 2018 Jan 8;5(1):ofx267. Epub 2017 Dec 8.

Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofx267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767946PMC
January 2018

Benefits of Direct-Acting Antivirals for Hepatitis C.

Ann Intern Med 2017 Dec 17;167(11):812-813. Epub 2017 Oct 17.

From University of Michigan, Ann Arbor, Michigan; Massachusetts General Hospital, Boston, Massachusetts; Mayo Clinic, Phoenix, Arizona; Duke University School of Medicine, Durham, North Carolina; and Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M17-1876DOI Listing
December 2017

Retreatment Options Following HCV Direct Acting Antiviral Failure.

Curr Treat Options Infect Dis 2017 Dec 4;9(4):389-402. Epub 2017 Nov 4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40506-017-0136-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726279PMC
December 2017

IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C.

Clin Infect Dis 2017 11;65(11):1773-1775

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cix620DOI Listing
November 2017

Comments on cochrane review on direct-acting antivirals for hepatitis C.

Hepatology 2017 10 26;66(4):1016-1019. Epub 2017 Aug 26.

Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.29366DOI Listing
October 2017

Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.

Authors:
Susanna Naggie

Top Antivir Med 2017 Feb/Mar;25(1):3-6

Duke University, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677037PMC
April 2017

Genotype 3 Infection: The Last Stand of Hepatitis C Virus.

Drugs 2017 Feb;77(2):131-144

Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-016-0685-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726887PMC
February 2017

Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.

Annu Rev Med 2017 01 23;68:345-358. Epub 2016 Sep 23.

Duke University School of Medicine and Duke Clinical Research Institute, Durham, North Carolina 27715; email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-052915-015720DOI Listing
January 2017

Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.

Clin Infect Dis 2017 Jan 28;64(1):92-99. Epub 2016 Sep 28.

Johns Hopkins School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159603PMC
January 2017

Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease.

Open Forum Infect Dis 2016 Sep 29;3(3):ofw173. Epub 2016 Aug 29.

Duke University Medical Center, Durham; Durham Veterans Affairs Medical Center; Duke Clinical Research Institute, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047416PMC
http://dx.doi.org/10.1093/ofid/ofw173DOI Listing
September 2016

Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study.

Clin Infect Dis 2016 08 3;63(3):407-13. Epub 2016 May 3.

Division of Infectious Diseases, Duke University Duke Clinical Research Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946018PMC
August 2016

The clinical management of HCV in the HIV-infected patient.

Antivir Ther 2015 27;20(5):457-67. Epub 2014 Oct 27.

Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP2910DOI Listing
May 2016

Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?

Clin Gastroenterol Hepatol 2015 Nov 17;13(12):2166-72. Epub 2015 Jul 17.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.07.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892426PMC
November 2015

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.

J Infect Dis 2015 Aug 12;212(3):367-77. Epub 2015 Jan 12.

Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007583PMC
August 2015

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

N Engl J Med 2015 Aug 21;373(8):705-13. Epub 2015 Jul 21.

From Duke Clinical Research Institute, Durham, NC (S.N.); University of Ottawa, the Ottawa Hospital, Ottawa (C.C.), and Department of Hepatology, Immunodeficiency Clinic, Toronto General Hospital, University of Toronto, Toronto (D.K.W.) - both in Canada; University of Alabama at Birmingham, Birmingham (M. Saag); Emory University, Emory Healthcare, Atlanta (K.W.); Ruane Medical and Liver Health Institute (P.R.) and Kaiser Permanente Los Angeles Medical Center (W.J.T.), Los Angeles, University of California, San Francisco, San Francisco General Hospital, San Francisco (A.L.), and Gilead Sciences, Foster City (L.M.S., J.C.Y., P.G., H.D.-S., L.N., P.S.P., J.G.M.) - all in California; Weill Cornell Medical College (K.M.), Icahn School of Medicine at Mount Sinai (N.B., D.D.), New York, and James J. Peters Veterans Affairs Medical Center, Bronx (N.B.) - all in New York; Beth Israel Deaconess Medical Center (R.P.B.), Brigham and Women's Hospital and Harvard Medical School (P.E.S.), and Community Research Initiative of New England (A.E.C.) - all in Boston; University of Auckland, Auckland City Hospital, Auckland (E.G.), and Christchurch Hospital and University of Otago, Christchurch (C.A.M.S.) - both in New Zealand; University of Puerto Rico School of Medicine (J.S.-B.) and Clinical Research Puerto Rico (J.O.M.-R.) - both in San Juan; University of Miami, Miami (D.J.); University of Pennsylvania, Philadelphia (P.T.); and Johns Hopkins University School of Medicine, Baltimore (M. Sulkowski).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892372PMC
August 2015

Successes and Challenges on the Road to Cure Hepatitis C.

PLoS Pathog 2015 Jun 18;11(6):e1004854. Epub 2015 Jun 18.

Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America; Duke Clinical Research Institute, Durham, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1004854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472668PMC
June 2015

PHOTON-2: hope for patients with HIV and HCV co-infection?

Lancet 2015 Mar 4;385(9973):1052-4. Epub 2015 Feb 4.

Division of Infectious Diseases, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60122-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936417PMC
March 2015

Community-based HCV screening: knowledge and attitudes in a high risk urban population.

BMC Infect Dis 2014 Feb 10;14:74. Epub 2014 Feb 10.

Division of Infectious Diseases and International Health, Duke University Medical Center, Box 102358, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2334-14-74DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945609PMC
February 2014

A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.

Trials 2014 Jan 22;15:31. Epub 2014 Jan 22.

Department of Epidemiology, Rollins School of Public Health, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1745-6215-15-31DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901894PMC
January 2014

Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.

Curr HIV/AIDS Rep 2013 Dec;10(4):408-19

Division of Infectious Diseases, Vanderbilt University Medical Center, A-2200 MCN, 1161 21st Avenue, Nashville, TN, 37232-2582, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11904-013-0182-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892376PMC
December 2013

Boceprevir for HCV in patients with HIV: where next?

Lancet Infect Dis 2013 Jul 12;13(7):563-4. Epub 2013 Jun 12.

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(13)70162-2DOI Listing
July 2013

Management of hepatitis C virus infection: the basics.

Authors:
Susanna Naggie

Top Antivir Med 2012 Dec;20(5):154-61

Duke University School of Medicine, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690573PMC
December 2012

Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.

AIDS Patient Care STDS 2012 Sep 3;26(9):541-5. Epub 2012 Aug 3.

Duke University Medical Center, Durham, North Carolina 22710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/apc.2012.0170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426196PMC
September 2012

Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Gastroenterology 2012 May;142(6):1324-1334.e3

Duke Clinical Research Institute, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2012.02.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637982PMC
May 2012

An integrated alcohol abuse and medical treatment model for patients with hepatitis C.

Dig Dis Sci 2012 Apr 2;57(4):1083-91. Epub 2011 Dec 2.

Duke Global Health Institute, Center for Health Policy and Inequalities Research, Duke University, 2812 Erwin Rd., #403, Durham, NC 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-011-1976-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586548PMC
April 2012

The Role of IL28B Genotype Testing in the Era of Direct Acting Antiviral Agents.

Eur Gastroenterol Hepatol Rev 2012 ;1(2):33-39

Assistant Professor, Duke Clinical Research Institute, Durham.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955390PMC
January 2012

Interleukin-28B gene polymorphisms do not influence the susceptibility to HIV-infection or CD4 cell decline.

AIDS 2011 Jan;25(2):269-71

Hospital Carlos III, Madrid, Spain bDuke Clinical Research Institute, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328341b84eDOI Listing
January 2011

Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors.

J Antimicrob Chemother 2010 Oct 4;65(10):2063-9. Epub 2010 Aug 4.

Duke Clinical Research Institute, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq284DOI Listing
October 2010

Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options.

J Antimicrob Chemother 2010 Jun 23;65(6):1094-9. Epub 2010 Apr 23.

Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkq130DOI Listing
June 2010

Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis.

Clin Chest Med 2009 Jun;30(2):337-53, vii-viii

Division of Infectious Diseases, Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccm.2009.02.009DOI Listing
June 2009

Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.

Infect Control Hosp Epidemiol 2008 Mar;29(3):197-202

Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia 30333, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/528813DOI Listing
March 2008

Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population.

AIDS Res Hum Retroviruses 2007 Oct;23(10):1230-6

Duke University Medical Center, Durham, North Carolina, 27710., Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2007.0053DOI Listing
October 2007